Paper in NEJM of May 12 mentions leronlimab AS AN
Post# of 145890
![Avatar](/images/ProfileImages/259520172_62777_mark2.jpg)
"The antiviral drugs, such as Selzentry (maraviroc) and Leronlimab (PRO 140), have been successfully used for treatment of AIDS. It is therefore of great interest to study whether these drugs can block cardiac infiltration of CD8+ T cells thereby reduce hypertensive cardiac injury of COVID-19 patients."
https://www.nature.com/articles/s41423-020-0454-3
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.